Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

PURPOSE: The randomized Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3) trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy (CTRT) versus radiotherapy alone (RT) for women with high-risk endometrial cancer (EC)....

Descripción completa

Detalles Bibliográficos
Autores principales: León-Castillo, Alicia, de Boer, Stephanie M., Powell, Melanie E., Mileshkin, Linda R., Mackay, Helen J., Leary, Alexandra, Nijman, Hans W., Singh, Naveena, Pollock, Pamela M., Bessette, Paul, Fyles, Anthony, Haie-Meder, Christine, Smit, Vincent T. H. B. M., Edmondson, Richard J., Putter, Hein, Kitchener, Henry C., Crosbie, Emma J., de Bruyn, Marco, Nout, Remi A., Horeweg, Nanda, Creutzberg, Carien L., Bosse, Tjalling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527156/
https://www.ncbi.nlm.nih.gov/pubmed/32749941
http://dx.doi.org/10.1200/JCO.20.00549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527156/
https://www.ncbi.nlm.nih.gov/pubmed/32749941
http://dx.doi.org/10.1200/JCO.20.00549

Ejemplares similares